Kanji Takahashi - Publications

A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: October 01, 2024

The effect of fibroblast growth factor 2 on neovascular vessels depends on the stage of angiogenesis.

Journal: Heliyon

Published: August 09, 2024

Cost-effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration and its Subtypes from the Societal and Patient Perspectives in Japan.

Journal: Ophthalmology and therapy

Published: May 28, 2024

Clinical and pathologic characteristics of inflamed juvenile conjunctival nevus and its treatment with immunosuppressant eye drops.

Journal: Japanese journal of ophthalmology

Published: February 20, 2024

Differences in collateral vessel formation after experimental retinal vein occlusion in spontaneously hypertensive rats and wild-type rats.

Journal: Heliyon

Published: November 08, 2023

Clinical Characteristics and Progression of Pachychoroid and Conventional Geographic Atrophy.

Journal: Ophthalmology science

Published: November 08, 2023

Correction: Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan.

Journal: Ophthalmology and therapy

Published: August 11, 2023

Phase I Study of Tivozanib Eye Drops in Healthy Volunteers and Patients with Neovascular Age-Related Macular Degeneration.

Journal: Ophthalmology science

Published: July 20, 2023

Treatment strategy for BVO-ME based on long-term outcomes correlating retinal structure by OCT image and visual acuity.

Journal: BMC ophthalmology

Published: May 25, 2023

Clinical Characteristics and Progression of Geographic Atrophy in a Japanese Population.

Journal: Ophthalmology. Retina

Published: April 05, 2023

Cost-Effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration in Japan.

Journal: Ophthalmology and therapy

Published: March 24, 2023

Potential for Treatment Interval Extension in Eyes with nAMD Disease Activity Post Loading Phase in HAWK and HARRIER.

Journal: Ophthalmology and therapy

Published: March 23, 2023